Irf8-Regulated Genomic Responses Drive Pathological Inflammation during Cerebral Malaria

PLoS Pathogens

Volumn 9, Issue 7, 2013, Pages

  Berghout, Joanne ^a   Langlais, David ^a   Radovanovic, Irena ^a   Tam, Mifong ^b   MacMicking, John D ^c   Stevenson, Mary M ^b   Gros, Philippe ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12P40; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BINDING SITE; BONE MARROW CELL; BRAIN MALARIA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE MUTATION; HIGH THROUGHPUT SEQUENCING; IMMUNE RESPONSE; INFECTION RESISTANCE; LUNG TUBERCULOSIS; LYMPHOID CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI INFECTION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TH1 CELL;

EID: 84884738365     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003491     Document Type: Article

References (70)

1. Tamura T, Yanai H, Savitsky D, Taniguchi T, (2008) The IRF family transcription factors in immunity and oncogenesis. AnnuRev Immunol 26: 535-584.
2. Wang H, Morse HC 3rd, (2009) IRF8 regulates myeloid and B lymphoid lineage diversification. Immunol Res 43: 109-117.
3. Marquis JF, Kapoustina O, Langlais D, Ruddy R, Dufour CR, et al. (2011) Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS Genet 7: e1002097.
4. Shi L, Perin JC, Leipzig J, Zhang Z, Sullivan KE, (2011) Genome-wide analysis of interferon regulatory factor I binding in primary human monocytes. Gene 487: 21-28.
5. Shin DM, Lee CH, Morse HC 3rd, (2011) IRF8 governs expression of genes involved in innate and adaptive immunity in human and mouse germinal center B cells. PLoS One 6: e27384.
6. Tamura T, Nagamura-Inoue T, Shmeltzer Z, Kuwata T, Ozato K, (2000) ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13: 155-165.
7. Holtschke T, Lohler J, Kanno Y, Fehr T, Giese N, et al. (1996) Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87: 307-317.
8. Turcotte K, Gauthier S, Mitsos LM, Shustik C, Copeland NG, et al. (2004) Genetic control of myeloproliferation in BXH-2 mice. Blood 103: 2343-2350.
9. Turcotte K, Gauthier S, Tuite A, Mullick A, Malo D, et al. (2005) A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice. J Exp Med 201: 881-890.
10. Gabriele L, Phung J, Fukumoto J, Segal D, Wang IM, et al. (1999) Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein. J Exp Med 190: 411-421.
11. Burchert A, Cai D, Hofbauer LC, Samuelsson MK, Slater EP, et al. (2004) Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2. Blood 103: 3480-3489.
12. Yang J, Hu X, Zimmerman M, Torres CM, Yang D, et al. (2011) Cutting edge: IRF8 regulates Bax transcription in vivo in primary myeloid cells. J Immunol 187: 4426-4430.
13. Tsujimura H, Tamura T, Ozato K, (2003) Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J Immunol 170: 1131-1135.
14. Aliberti J, Schulz O, Pennington DJ, Tsujimura H, Reis e Sousa C, et al. (2003) Essential role for ICSBP in the in vivo development of murine CD8alpha+dendritic cells. Blood 101: 305-310.
15. Schiavoni G, Mattei F, Sestili P, Borghi P, Venditti M, et al. (2002) ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J Exp Med 196: 1415-1425.
16. Wang H, Lee CH, Qi C, Tailor P, Feng J, et al. (2008) IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood 112: 4028-4038.
17. Wang IM, Contursi C, Masumi A, Ma X, Trinchieri G, et al. (2000) An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J Immunol 165: 271-279.
18. Giese NA, Gabriele L, Doherty TM, Klinman DM, Tadesse-Heath L, et al. (1997) Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J Exp Med 186: 1535-1546.
19. Zhu C, Rao K, Xiong H, Gagnidze K, Li F, et al. (2003) Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP. J Biol Chem 278: 39372-39382.
20. Liu J, Guan X, Tamura T, Ozato K, Ma X, (2004) Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J Biol Chem 279: 55609-55617.
21. Kim YM, Kang HS, Paik SG, Pyun KH, Anderson KL, et al. (1999) Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression. J Immunol 163: 2000-2007.
22. Marquis JF, LaCourse R, Ryan L, North RJ, Gros P, (2009) Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8. J Immunol 182: 3008-3015.
23. Ouyang X, Zhang R, Yang J, Li Q, Qin L, et al. (2011) Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun 2: 314.
24. Scharton-Kersten T, Contursi C, Masumi A, Sher A, Ozato K, (1997) Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J Exp Med 186: 1523-1534.
25. Fehr T, Schoedon G, Odermatt B, Holtschke T, Schneemann M, et al. (1997) Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. J Exp Med 185: 921-931.
26. Hein J, Kempf VA, Diebold J, Bucheler N, Preger S, et al. (2000) Interferon consensus sequence binding protein confers resistance against Yersinia enterocolitica. Infect Immun 68: 1408-1417.
27. Turcotte K, Gauthier S, Malo D, Tam M, Stevenson MM, et al. (2007) Icsbp1/IRF-8 is required for innate and adaptive immune responses against intracellular pathogens. J Immunol 179: 2467-2476.
28. Alter-Koltunoff M, Goren S, Nousbeck J, Feng CG, Sher A, et al. (2008) Innate immunity to intraphagosomal pathogens is mediated by interferon regulatory factor 8 (IRF-8) that stimulates the expression of macrophage-specific Nramp1 through antagonizing repression by c-Myc. J Biol Chem 283: 2724-2733.
29. Fortier A, Doiron K, Saleh M, Grinstein S, Gros P, (2009) Restriction of Legionella pneumophila replication in macrophages requires concerted action of the transcriptional regulators Irf1 and Irf8 and nod-like receptors Naip5 and Nlrc4. Infect Immun 77: 4794-4805.
30. Ko J, Gendron-Fitzpatrick A, Splitter GA, (2002) Susceptibility of IFN regulatory factor-1 and IFN consensus sequence binding protein-deficient mice to brucellosis. J Immunol 168: 2433-2440.
31. Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, et al. (2011) IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med 365: 127-138.
32. Cunninghame Graham DS, Morris DL, Bhangale TR, Criswell LA, Syvanen AC, et al. (2011) Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet 7: e1002341.
33. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43: 246-252.
34. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: 955-962.
35. Elding H, Lau W, Swallow DM, Maniatis N, (2011) Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease. Am J Hum Genet 89: 798-805.
36. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41: 776-782.
37. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, et al. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
38. International Multiple Sclerosis Genetics Consortium (2011) The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control study. PLoS One 6: e18813.
39. Berghout J, Min-Oo G, Tam M, Gauthier S, Stevenson MM, et al. (2010) Identification of a novel cerebral malaria susceptibility locus (Berr5) on mouse chromosome 19. Genes Immun 11: 310-318.
40. Dorovini-Zis K, Schmidt K, Huynh H, Fu W, Whitten RO, et al. (2011) The neuropathology of fatal cerebral malaria in malawian children. Am J Pathol 178: 2146-2158.
41. Medana IM, Turner GD, (2006) Human cerebral malaria and the blood-brain barrier. Int J Parasitol 36: 555-568.
42. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9: R137.
43. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
44. Sanni LA, Thomas SR, Tattam BN, Moore DE, Chaudhri G, et al. (1998) Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am J Pathol 152: 611-619.
45. Bongfen SE, Rodrigue-Gervais IG, Berghout J, Torre S, Cingolani P, et al. (2012) An N-Ethyl-N-Nitrosourea (ENU)-Induced Dominant Negative Mutation in the JAK3 Kinase Protects against Cerebral Malaria. PLoS One 7: e31012.
46. Tan RS, Feng C, Asano Y, Kara AU, (1999) Altered immune response of interferon regulatory factor 1-deficient mice against Plasmodium berghei blood-stage malaria infection. Infect Immun 67: 2277-2283.
47. Gramaglia I, Sahlin H, Nolan JP, Frangos JA, Intaglietta M, et al. (2005) Cell- Rather Than Antibody-Mediated Immunity Leads to the Development of Profound Thrombocytopenia during Experimental Plasmodium berghei Malaria. The Journal of Immunology 175: 7699-7707.
48. Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, et al. (1993) Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75: 83-97.
49. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, et al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119-124.
50. Feng J, Wang H, Shin DM, Masiuk M, Qi CF, et al. (2011) IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools. J Immunol 186: 1458-1466.
51. Chen L, Zhang ZH, Sendo F, (2000) Neutrophils play a critical role in the pathogenesis of experimental cerebral malaria. Clinical & Experimental Immunology 120: 125-133.
52. Porcherie A, Mathieu C, Peronet R, Schneider E, Claver J, et al. (2011) Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria. The Journal of Experimental Medicine 208: 2225-2236.
53. Claser C, Malleret B, Gun SY, Wong AYW, Chang ZW, et al. (2011) CD8+ T Cells and IFN-γ Mediate the Time-Dependent Accumulation of Infected Red Blood Cells in Deep Organs during Experimental Cerebral Malaria. PLoS ONE 6: e18720.
54. Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, et al. (2008) Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci U S A 105: 4814-4819.
55. Li J, Chang WL, Sun G, Chen HL, Specian RD, et al. (2003) Intercellular adhesion molecule 1 is important for the development of severe experimental malaria but is not required for leukocyte adhesion in the brain. J Investig Med 51: 128-140.
56. Roebuck KA, Finnegan A, (1999) Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 66: 876-888.
57. Senaldi G, Shaklee CL, Guo J, Martin L, Boone T, et al. (1999) Protection against the mortality associated with disease models mediated by TNF and IFN-gamma in mice lacking IFN regulatory factor-1. J Immunol 163: 6820-6826.
58. Tamura T, Kimura K, Yuda M, Yui K, (2011) Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA. Infect Immun 79: 3947-3956.
59. Lundie RJ, de Koning-Ward TF, Davey GM, Nie CQ, Hansen DS, et al. (2008) Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells. Proc Natl Acad Sci U S A 105: 14509-14514.
60. van der Heyde HC, Pepper B, Batchelder J, Cigel F, Weidanz WP, (1997) The time course of selected malarial infections in cytokine-deficient mice. Exp Parasitol 85: 206-213.
61. Longley R, Smith C, Fortin A, Berghout J, McMorran B, et al. (2011) Host resistance to malaria: using mouse models to explore the host response. Mamm Genome 22: 32-42.
62. Yamada H, Mizuno S, Sugawara I, (2002) Interferon regulatory factor 1 in mycobacterial infection. Microbiol Immunol 46: 751-760.
63. MacMicking JD, Taylor GA, McKinney JD, (2003) Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302: 654-659.
64. Sousa AO, Mazzaccaro RJ, Russell RG, Lee FK, Turner OC, et al. (2000) Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci U S A 97: 4204-4208.
65. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41: 1228-1233.
66. Pino PA, Cardona AE, (2011) Isolation of brain and spinal cord mononuclear cells using percoll gradients. J Vis Exp.
67. Du P, Kibbe WA, Lin SM, (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548.
68. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, et al. (2006) TM4 microarray software suite. Methods Enzymol 411: 134-193.
69. Langlais D, Couture C, Sylvain-Drolet G, Drouin J, (2011) A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells. Mol Endocrinol 25: 348-359.
70. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.